Yoshiyuki Taoda

Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19

Yuto Unoh, Shota Uehara, Kenji Nakahara et al. · Journal of Medicinal Chemistry · 2022 · 590 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

Epigenetic Regulation of Autophagy by the Methyltransferase G9a

Amaia Artal-Martinez de Narvajas, Timothy S. Gomez, Jin‐San Zhang et al. · Molecular and Cellular Biology · 2013 · 218 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Carbamoyl Pyridone HIV-1 Integrase Inhibitors 3. A Diastereomeric Approach to Chiral Nonracemic Tricyclic Ring Systems and the Discovery of Dolutegravir (S/GSK1349572) and (S/GSK1265744)

Brian A. Johns, Takashi Kawasuji, Jason G. Weatherhead et al. · Journal of Medicinal Chemistry · 2013 · 184 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Boron Cluster-based Development of Potent Nonsecosteroidal Vitamin D Receptor Ligands: Direct Observation of Hydrophobic Interaction between Protein Surface and Carborane

Shinya Fujii, Hiroyuki Masuno, Yoshiyuki Taoda et al. · Journal of the American Chemical Society · 2011 · 117 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Carbamoyl Pyridone HIV-1 Integrase Inhibitors. 2. Bi- and Tricyclic Derivatives Result in Superior Antiviral and Pharmacokinetic Profiles

Takashi Kawasuji, Brian A. Johns, Hiroshi Yoshida et al. · Journal of Medicinal Chemistry · 2013 · 92 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13